JAMT reports year-end profit attributable to shareholders of $260.64 million

November 12, 2025

Jamaica Teas Limited (JAMT)

Unaudited Financials for the Twelve Months Ended September 30, 2025

Jamaica Teas Limited (JAMT) reported a 10% increase in Operating Revenues for the twelve months ended September 30, 2025, totaling $3.49 billion compared to $3.18 billion in the corresponding period last year. Operating Revenues for the fourth quarter rose by 9% to $855.33 million, up from $782.01 million in the comparable quarter of 2024.

Cost of Sales amounted to $2.75 billion (2024: $2.58 billion), reflecting a 7% year-over-year increase. As a result, Gross Profit grew by 22% to $740.49 million compared to $607.61 million for the same period in 2024. The company recorded a Gross Profit of $200.49 million for the fourth quarter versus $114.67 million in the corresponding quarter of 2024.

Other Income declined by 55% to $49.49 million (2024: $109.55 million). Sales and Marketing Costs decreased by 7%, moving from $47.47 million in 2024 to $43.93 million during the review period. Administrative Expenses for the twelve months ended September 30, 2025, totalled $506.17 million, representing a 10% increase relative to $450.68 million reported in 2024.

Finance Costs for the twelve months amounted to $66.20 million, a 16% increase from $56.98 million in 2024. For the fourth quarter, Finance Costs were $15.54 million compared to $18.88 million in the prior year. Profit Before Taxation totalled $322.46 million, a 5% increase over the corresponding period in 2024 ($305.81 million).

The Taxation charge for the twelve months ended September 30, 2025, amounted to $50.03 million, representing a 49% decline from $98.50 million in 2024. The Taxation charge for the fourth quarter was $47.78 million (2024: $210,093).

Net Profit for the twelve months increased by 31% to $272.43 million (2024: $207.31 million). Net Profit for the quarter rose sharply by 284% to $203.93 million (2024: $53.09 million). Profit attributable to shareholders for the twelve months amounted to $260.64 million, reflecting a 110% increase from $124.22 million in 2024. For the fourth quarter, Profit attributable to shareholders was $141.28 million (2024: $39.59 million).

Total comprehensive income attributable to shareholders for the year ended September 30, 2025, amounted to $260.64 million, compared to $192.08 million in 2024. For the fourth quarter, total comprehensive income attributable to shareholders was $141.28 million, compared to $39.59 million in the prior year.

Earnings Per Share for the twelve months amounted to $0.12, compared to $0.057 in 2024. Earnings Per Share for the fourth quarter totalled $0.065, compared to $0.018 in the prior year. The figure was derived from the total comprehensive income attributable to shareholders, based on 2,179,680,377 shares in issue.

As of November 11, 2025, JAMT’s stock price closed at $2.21, corresponding to a P/E ratio of 18.48x.

Balance Sheet Highlights
The company’s total assets stood at $5.65 billion (2024: $5.55 billion), driven primarily by higher inventories amounting to $739.52 million (2024: $557.27 million).

Shareholders’ equity increased to $3.35 billion (2024: $3.13 billion), representing a book value per share of $1.54 compared to $1.43 in 2024

 

Disclaimer:

Analyst Certification – The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation (s) or view (s) expressed by that research analyst in this research report.

Company Disclosure – The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.

More Stories from the Market
shutterstock_609342323
March 25, 2026   Sagicor Group Jamaica Limited (SJ) has declared a dividend of $0.89 per stock unit payable on May 6, 2026, to stockholders…
shutterstock_148562033
March 25, 2026   Pan Jamaica Group Limited (PJAM) has advised that a senior officer purchased 276,992 PJAM shares on March 24, 2026. &…
shutterstock_453968572
March 25, 2026   Pan Jamaica Group Limited (PJAM) has advised that on March 24, 2026, three Directors were issued a total of 50,634 PJAM sh…
shutterstock_148562033
March 25, 2026   Supreme Ventures Limited (SVL) has advised that on March 17, 2026, a Director purchased 319,424 SVL shares and a related e…
shutterstock_148562033
March 25, 2026   IronRock Insurance Company Limited (ROC) has advised that connected parties sold a total of 70,939 ROC shares during the p…
shutterstock_453968572
March 25, 2026 United States: US Import Prices Jumped by the Most Since 2022 Ahead of War   The cost of imports into the US jumped in Febr…
shutterstock_537598660
March 24, 2026 Indies Pharma Jamaica Limited (INDIES) Unaudited financials for the first quarter ended January 31, 2026: Indies Pharma Jama…
shutterstock_609342323
March 24, 2026   Indies Pharma Jamaica Limited (INDIES) has declared an interim dividend of $0.135 per stock unit payable on April 30, 2026…